Inspire Medical Systems (NYSE: INSP) director receives 581-share stock fee award

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. director Gary Lee Ellis received an equity grant of 581 shares of common stock on July 15, 2026, reported as a grant/award acquisition. According to a footnote, these shares were issued in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, at a stated price of $0.0000 per share. Following this award, Ellis directly holds 11,419 shares of Inspire Medical Systems common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ellis Gary Lee

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	581	$0.00	--

Holdings After Transaction: Common Stock — 11,419 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 581 shares Price per share: $0.0000 Shares owned after grant: 11,419 shares

3 metrics

Shares granted 581 shares Common stock grant to Gary Lee Ellis on July 15, 2026

Price per share $0.0000 Stated value for shares received in lieu of cash fees

Shares owned after grant 11,419 shares Total direct common stock holdings of Gary Lee Ellis after the award

Key Terms

Non-Employee Director Compensation Policy, Power of Attorney, grant, award, or other acquisition

3 terms

Non-Employee Director Compensation Policy financial

"pursuant to the Company's Non-Employee Director Compensation Policy."

Power of Attorney regulatory

"Remarks: Exhibit 24 - Power of Attorney."

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 09:26 PM Accepted by SEC EDGAR 07/17/2026 - 09:25 PM Learn about SEC filing dates

FAQ

What transaction did Gary Lee Ellis report for Inspire Medical Systems (INSP)?

Gary Lee Ellis reported receiving 581 shares of Inspire Medical Systems common stock as a grant/award acquisition on July 15, 2026. The shares were issued as part of his non-employee director compensation, in stock rather than cash fees, and are held directly.

Why did Gary Lee Ellis receive 581 INSP shares instead of cash?

Ellis received 581 shares of Inspire Medical Systems common stock in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. This means a portion of his director compensation was paid in stock rather than cash, aligning his compensation with equity.

How many Inspire Medical Systems (INSP) shares does Gary Lee Ellis own after this filing?

After the reported grant, Gary Lee Ellis directly owns 11,419 shares of Inspire Medical Systems common stock. This total includes the newly awarded 581 shares received as stock compensation under the Non-Employee Director Compensation Policy for non-employee directors.

What was the transaction price per share in the INSP Form 4 filing?

The transaction lists a price of $0.0000 per share for the 581 Inspire Medical Systems shares. This reflects that the shares were granted as compensation, received in lieu of cash fees, rather than purchased in an open-market transaction at a cash price.

What transaction code was used in Gary Lee Ellis’s INSP Form 4?

The filing uses transaction code A, which indicates a grant, award, or other acquisition of securities. In this case it corresponds to the award of 581 shares of common stock under the Non-Employee Director Compensation Policy, not an open-market purchase.

Was Gary Lee Ellis’s INSP stock award reported under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox is not marked as true, so the award was not reported as made under a Rule 10b5-1 trading plan. It is characterized instead as equity compensation under the company’s Non-Employee Director Compensation Policy.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellis Gary Lee

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		A		581(1)	A	$0	11,419	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Gary L. Ellis	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)